Adastra Holdings Ltd
adastraholdings.caNo Longer Reporting
The company has not filed an annual or quarterly report since its FY2022 20-F, filed May 17, 2023. Its latest SEC filing is a 15-12G from May 1, 2024.
20-F for FY2022, filed May 17, 2023
The sections below describe the company as of the FY2022 annual report.
What Did They Do?
Processes cannabis into extracts, tests cannabis for licensed producers, and provides processing solutions to cultivators; also operates a medical cannabis clinic for patients.
20-F for FY2022, filed May 17, 2023We are an integrated Canadian cannabis company focused on extraction and associated analytical testing. We, through one of our wholly owned…View ↗
We are an extraction and processing solutions company. Our mission is to develop and deploy large-scale cannabis and hemp extraction…View ↗
On August 31, 2021, we acquired all of the issued and outstanding common shares of 1225140 B.C. Ltd., doing business as PerceiveMD…View ↗
Who Were Their Customers?
Licensed cannabis producers and cultivators use its extraction and testing services; patients receive medical consultations, and licensed health practitioners may buy cannabis extracts.
20-F for FY2022, filed May 17, 2023We are an extraction and processing solutions company. Our mission is to develop and deploy large-scale cannabis and hemp extraction…View ↗
On August 31, 2021, we acquired all of the issued and outstanding common shares of 1225140 B.C. Ltd., doing business as PerceiveMD…View ↗
On August 12, 2022, the Company received its medical sales licence (the "Medical Sales Licence") that permits the Company to sell cannabis…View ↗
We are an integrated Canadian cannabis company focused on extraction and associated analytical testing. We, through one of our wholly owned…View ↗
Loading...
